Emoto Y, Emoto M, Kaufmann S H
Department of Immunology, University of Ulm, Germany.
Infect Immun. 1997 Dec;65(12):5003-9. doi: 10.1128/iai.65.12.5003-5009.1997.
Unconstrained development of gamma interferon (IFN-gamma)-secreting natural killer (NK) cells and T helper (Th) 1 cells is central to protection against Listeria monocytogenes. In contrast, interleukin 4 (IL-4) is considered harmful. IL-12 produced by infected macrophages promotes, and IL-4 interferes with, protective antilisterial immunity. The liver NK T lymphocytes, which are a potent source of IL-4, are downregulated at an intermediate stage of listeriosis. Here we demonstrate that endogenous IL-12 participates in the control of IL-4-producing liver NK T lymphocytes during listeriosis. The effects of L. monocytogenes infection on IL-4-producing liver NK T lymphocytes were reversed by antibody neutralization of IL-12 but not of IFN-gamma or tumor necrosis factor alpha (TNF-alpha). IL-4 production by liver NK T lymphocytes was virtually unaffected by heat-killed L. monocytogenes (HKL). Viable L. monocytogenes markedly increased the numbers of IL-12 producers in livers in parallel with an increase in macrophage numbers, whereas HKL failed to do so with similar efficiency. These results indicate that in the liver endogenous IL-12 improves protective immunity against listeriosis by downregulating IL-4-producing NK T lymphocytes. Moreover, our findings that HKL have a low level of IL-12-inducing activity and fail to control IL-4-producing NK T lymphocytes in the liver are consistent with the lesser protective capacity of HKL compared to that of live listeriae.
分泌γ干扰素(IFN-γ)的自然杀伤(NK)细胞和辅助性T细胞1(Th1)细胞的无限制发育是抵御单核细胞增生李斯特菌的关键。相比之下,白细胞介素4(IL-4)被认为是有害的。受感染巨噬细胞产生的IL-12促进保护性抗李斯特菌免疫,而IL-4则干扰这种免疫。肝脏NK T淋巴细胞是IL-4的一个强大来源,在李斯特菌病的中间阶段会下调。在这里,我们证明内源性IL-12在李斯特菌病期间参与了对产生IL-4的肝脏NK T淋巴细胞的控制。单核细胞增生李斯特菌感染对产生IL-4的肝脏NK T淋巴细胞的影响可通过IL-12的抗体中和作用逆转,但IFN-γ或肿瘤坏死因子α(TNF-α)的抗体中和作用则不能。肝脏NK T淋巴细胞产生IL-4的情况实际上不受热灭活的单核细胞增生李斯特菌(HKL)的影响。活的单核细胞增生李斯特菌显著增加了肝脏中产生IL-12的细胞数量,同时巨噬细胞数量也增加,而HKL则不能以类似的效率做到这一点。这些结果表明,在肝脏中,内源性IL-12通过下调产生IL-4的NK T淋巴细胞来提高对李斯特菌病的保护性免疫。此外,我们发现HKL诱导IL-12的活性水平较低,并且无法控制肝脏中产生IL-4的NK T淋巴细胞,这与HKL相比活李斯特菌的保护能力较弱是一致的。